Internal Medicine Department, Hospital Cheikh Zayed, Nouakchott, Mauritania
Endocrinology Department, CHU Farhat Hachad Sousse, Sousse, Tunisia
Research Unit of Biology, Genetics of Cancers, Haematological and Autoimmune Diseases, Faculty of Pharmacy of Monastir, University of Monastir, Monastir, Tunisia
Endocrinology Department, CHU Farhat Hachad Sousse, Sousse, Tunisia
Copyright © 2017 Mohamed Moustapha, Molka Chadhli-Chaieb, Touhami Mahjoub, Larbi Chaieb et al. This is
an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any
medium, provided the original work is properly cited.
How to Cite this Article
Moustapha, M. , Chadhli-Chaieb, M. , Mahjoub, T. and Chaieb, L. (2017) Genetic and Metabolic Determinants of Plasminogen Activator Inhibitor 1 (PAI-1) in Tunisian Type 2 Diabetes Patients.
Open Journal of Endocrine and Metabolic Diseases,
7, 141-150. doi:
10.4236/ojemd.2017.76013.